Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03970226 · ClinicalTrials.gov registry record · Early Phase 1
Tocilizumab in Children With ACP
A Early Phase 1 study of Adamantinomatous Craniopharyngioma, sponsored by University of Colorado, Denver.
- Active
- Registry status
- Early Phase 1
- Development phase
- 9
- Enrollment target
- 1
- Study location
NCT03970226 is a Early Phase 1 study of Adamantinomatous Craniopharyngioma that is active but no longer recruiting, run by University of Colorado, Denver. The registered enrollment target is 9 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03970226, a Early Phase 1 study of Adamantinomatous Craniopharyngioma, is active but no longer recruiting, sponsored by University of Colorado, Denver.
- ACTIVE NOT RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 9 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will be conducted in two phases. The first phase (phase 0) will be looking at patients with new or recurrent/ progressed craniopharyngioma tumors. These patients will be given one dose of tocilizumab before they have SOC surgery of their tumor. The objective of this phase is to see if drug reaches the tumor. If phase 0 is favorable and shows that drug is penetrating the tumor, the second phase of the study (feasibility phase) will open. Both phases will remain open concurrently and patients will be able to enroll on the Phase 0 then "roll over" and enroll on the feasibility phase. During the feasibility phase patients will be administered tocilizumab every two weeks for up to 13 cycles (approximately 1 year). Patients will be followed for up to 5 years in the feasibility phase.
Conditions Studied
Interventions
- DRUG Tocilizumab
Study Locations (1)
Colorado
- Children's Hospital Colorado - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2019-09-16 |
| Est. Completion | 2027-05 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03970226
The ClinicalTrials.gov registry entry for NCT03970226 describes a study currently listed as active not recruiting, categorized as Early Phase 1. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Adamantinomatous Craniopharyngioma appearing as the primary indexed condition, and to 1 intervention - of which Tocilizumab is the first listed.
NCT03970226 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT03970226 about?
NCT03970226 is a clinical study titled "Tocilizumab in Children With ACP". This study will be conducted in two phases. The first phase (phase 0) will be looking at patients with new or recurrent/ progressed craniopharyngioma tumors. These patients will be given one dose of tocilizumab before they have SOC surgery of their tumor. The objective of this phase is to see if dru...
What is the current status of trial NCT03970226?
This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 9 participants. The study started on 2019-09-16. Estimated completion is 2027-05.
What conditions does trial NCT03970226 study?
This clinical trial studies the following conditions: Adamantinomatous Craniopharyngioma.
What interventions are being tested in trial NCT03970226?
The interventions under investigation include: Tocilizumab (DRUG).
Who is sponsoring clinical trial NCT03970226?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03970226 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Adamantinomatous Craniopharyngioma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.